Men's health in China

Journal of Men's Health and Gender

Volumn 4, Issue 1, 2007, Pages 13-17

  Sun, Yinghao ^a   Liu, Zhiyong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chinese men; Erectile dysfunction; Men's health; Partial androgen deficiency; Prostate cancer

Indexed keywords

ADVANCED CANCER; AGING; ANDROGEN DEFICIENCY; CANCER DIAGNOSIS; CANCER MORTALITY; CHINA; DEVELOPING COUNTRY; ERECTILE DYSFUNCTION; HUMAN; INCIDENCE; MEN'S HEALTH; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 33847629690     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2006.12.001     Document Type: Review

References (42)

1. Agency for Healthcare Research and Quality. AHRQ focus on research: Issues in men's health care. Avaliable at: www://ahrq.gov/news/focus/menshc.htm. Accessed December 22, 2005.
2. National Center for Health Statistics. Overweight, obesity and healthy weight among persons 20 years of age and over, according to sex, age, race, and Hispanic origin: United States, 1960-62, 1971-74, 1976-80, 1988-94, and 1999-2002. In: Health, United States, 2004. Hyattsville, MD: NCHS, 2004: Table 69, pp. 241. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/Health_US/hus04tables/Table069.xls.
3. Cromie WJ. Why women live longer than men. Cambridge, MA: The Harvard University Gazette. Available at: http://www.hno.harvard.edu/gazette/1998/10.01/WhyWomenLiveLon.html.
4. Suiming Pan. The factors inhibited Chinese people to answer questions on sexuality. Presented at the annual conference of the Society of Scientific Studies on Sexuality, Pittsburgh, USA, May 1-5, 1996.
5. Jardin A, Wagner G, Khoury S, Giuliano F, Padam-Nathan H, Rosen R, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Société Internationale d'Urologie (SIU), 1-3 July 1999, Paris 2000, p. 713.
6. Tan H-M, Ng C-J, Low W-Y, Fisher W, Sand M. Prevalence of erectile dysfunction and treatment: preliminary results from three countries in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES). Poster presented at the International Congress of Andrology, 13-15 June 2005. Seoul, Korea.
7. Jing L. The study of epidemiology of erectile dysfunction in 1582 Chinese men over 40 years old in Shanghai urban area. Chin J Androl 14 1 (2000) 29-31
8. Zhang Q. Male sexual function study in three Chinese cities on 2226 males. Chin J Androl 17 3 (2003) 91-193
9. Low W-Y, Tan H-M, Ng C-J, Fisher W, Sand M. Does quality of life differ between men with and without erectile dysfunction? Preliminary results from three countries in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES). Poster presented at the International Congress of Andrology, 13-15 June 2005. Seoul, Korea.
10. Ng C-J, Tan H-M, Low W-Y, Fisher W, Sand M. Prevalence of comorbidities in men with erectile dysfunction in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES): Preliminary results from three countries. Poster presented at the International Congress of Andrology, 13-15 June 2005. Seoul, Korea.
11. Wang W. Traditional Chinese medical treatment to ED. Chin Gen Pract 5 1 (2002) 19-20
12. Qin G. Regularity study on erectile dysfunction and biotypology of Chinese medicine. J Beijing Univ Tradit Chin Med 28 4 (2005) 74-78
13. Matsumoto A.M. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57A (2002) M76-M99
14. Araujo A.B., O'Donell A.B., Bambilla D.J., Simpson W.B., Longcope C., Matsumoto A.M., et al. Prevalence and incidence of androgen deficiency in middle-age and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89 (2004) 5920-5926
15. McLaghlan R.I., and Allan C.A. Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts?. J Clin Endocrinol Metab 89 (2004) 5916-5919
16. Ferrini R.L., and Connor-Barrett E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147 (1998) 750-754
17. Wu J., Zhou Q.-x., Shen Z.-h., Bao Z.-g., Weng Y.-l., and Qian Y.-f. Epidemiological investigation of partial androgen deficiency in aging male (PADAM) in the Island Area. Dis Surveill 21 4 (2004) 208-211
18. Zhou Q. Partial androgen deficiency in aging male (PADAM) in the ZhouShan. Chin Prev Med 2 (2006) 130-133
19. Anderson J.K., Faulkner S., Cranor C., Briley J., Gevirtz F., Robert S., et al. Andropause: knowledge and perceptions among the general public and health care professionals. J Gerontol A Biol Sci Med Sci 57 12 (2002) 793-796
20. Lu S. Epidemiological investigation of male menopause. Chin J Androl 16 4 (2002) 321-324
21. Guo Y. Challenge for men's health in China. Chin J Androl 9 1 (2003) 321-324
22. Xie Z. Clinical research of Huanshaodan on treating partial androgen deficiency in aging male. Zhejiang JITCWM 12 15 (2005) 734-736
23. Lu M. Treatment of partial androgen deficiency of the ageing male (PADAM) with Zhonghe decoction (a report of 30 cases). Chin J Hum Sex 14 9 (2005) 9-11
24. Zheng X., and Pei L. Clinical thinking on acupuncture-moxibustion treatment of partial androgen deficiency in aging men. Shanghai J Acu-mox 25 4 (2006) 28-29
25. Parkin D.M. Global Cancer Statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
26. Liu Z. Incidence trends of prostate cancer in urban Shanghai. Chin J Health Stat 6 (2003) 335-337
27. Zhang W. Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai. Chin J Cancer 24 1 (2004) 11-15
28. Xu Z. The incidence of prostatic carcinoma in Shanghai. Chin J Clin Med 10 3 (2003) 344-346
29. Jiang Q. An analysis of epidemiological feature of prostate cancer in the period 1980-1999 in Yangpu District, Shanghai. Bull Chin Cancer 11 5 (2002) 263-264
30. Wang L. Epidemic trend of common malignancies from 1983 to 2001 in Yangpu District, Shanghai. Bull Chin Cancer (2004) 11
31. Hankey B.F., Feuer E.J., Clegg L.X., Hayes R.B., Legler J.M., Prorok P.C., et al. Cancer surveillance series: interpreting trends in prostate cancer - part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91 (1999) 1017-1024
32. National Institutes of Health. Recent Trends in Prostate Cancer Incidence and Mortality. Available at: http://www.nih.gov/news/pr/nov97/nci-21.htm.
33. Zhang Y. The relation of PSA level and the diagnosis and treatment of prostate cancer. Contin Med Educ 11 (2006) 9-11
34. Qiu C. Epidemiological characteristics of prostate cancer in Wuhan, China. Chin J Public Health 5 (1999) 47-49
35. Qian W. Mortality from urinary and male genital diseases in the population of Shanghai Hongkou district in recent years. Chin J Urol 22 11 (2001) 645-650
36. Peyromaure M., Debre B., Mao K., Zhang G., Huang Y., Sun Y., et al. Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol 174 5 (2005) 1794-1797
37. Murphy A.M., McKiernan J.M., and Olsson C.A. Controversies in prostate cancer screening. J Urol 172 (2004) 1822-1824
38. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., Scardino P.T., et al. Cancer control with radical prostatectomy alone in 1000 consecutive cases. J Urol 167 (2002) 528-534
39. Huang Y. Clinical analysis of radical retropubic prostatectomy: a report of 132 cases. Chin J Surg 44 6 (2006) 365-368
40. Li A. Laparoscopic radical prostatectomy: an evaluation of 159 cases. Chin J Urol 26 12 (2005) 816-819
41. Shao Q. A preliminary study of PSA level in 646 healthy men in Beijing. Natl Med J Chin 80 8 (2000) 591-592
42. Zhou L. Variation of serum PSA with age in benign prostatic hyperplasia patients. Chin J Urol 23 5 (2002) 293